Przejdź do trybu offline z Player FM !
Can DNA test determine your best skincare routine? I gave it a try.
Manage episode 358252010 series 3458408
Our guest today is dr. Barbara Geusens, Founder of Nomige, a woman passionate about science
In 2017 Barbara founded Nomige after her struggle with unbalanced, acne-prone skin and had tried numerous brands to solve her problem. She was disappointed by the poor results and the acne that kept coming back, so she decided to use her knowledge gained during her PhD at the department of dermatology in Ghent, Belgium and launched her own brand Nomige: a line of personalized products that are fully tailored to your needs, based on your DNA and lifestyle. A unique approach for a unique skin.
Nomige is the first Belgian brand to offer facial care products that are completely tailored to a person's DNA and lifestyle . For more information visit https://www.nomige.com/
69 odcinków
Manage episode 358252010 series 3458408
Our guest today is dr. Barbara Geusens, Founder of Nomige, a woman passionate about science
In 2017 Barbara founded Nomige after her struggle with unbalanced, acne-prone skin and had tried numerous brands to solve her problem. She was disappointed by the poor results and the acne that kept coming back, so she decided to use her knowledge gained during her PhD at the department of dermatology in Ghent, Belgium and launched her own brand Nomige: a line of personalized products that are fully tailored to your needs, based on your DNA and lifestyle. A unique approach for a unique skin.
Nomige is the first Belgian brand to offer facial care products that are completely tailored to a person's DNA and lifestyle . For more information visit https://www.nomige.com/
69 odcinków
Όλα τα επεισόδια
×Zapraszamy w Player FM
Odtwarzacz FM skanuje sieć w poszukiwaniu wysokiej jakości podcastów, abyś mógł się nią cieszyć już teraz. To najlepsza aplikacja do podcastów, działająca na Androidzie, iPhonie i Internecie. Zarejestruj się, aby zsynchronizować subskrypcje na różnych urządzeniach.